Drug intelligence / Profile preview

Rupining

Development stage
Unknown
Lead developer
Wuhan Pharmaceutical Valley Technology Development
Modality
Small Molecules
Administration
Oral
01

Overview

Rupining is a Traditional Chinese Medicine (TCM) formulation developed by Wuhan Pharmaceutical Valley Technology Development Co., Ltd., specifically indicated for the treatment of breast hyperplasia (lobular hyperplasia) and associated breast pain. The medication is typically formulated as tablets and contains a complex blend of herbal extracts, including *Sparganium stoloniferum*, *Curcuma zedoaria*, and *Prunella vulgaris*. Its mechanism of action involves "softening hardness and dissipating nodules" and "soothing the liver and regulating qi" according to TCM principles. Pharmacologically, it is thought to modulate the endocrine environment, particularly by balancing estrogen and progesterone levels, and providing anti-inflammatory and analgesic effects to reduce mammary gland congestion and hyperplasia.

Brand names
Rupining
Other names
Ru Pi NingRupining Pian
02

Targets

ER (Estrogen receptor)PR (Progesterone receptor)

Beyond the preview

Go deeper on Rupining.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rupining.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call